Description
Dermorphin is a naturally occurring peptide belonging to the opioid peptide family, originally isolated from the skin of South American tree frogs (Phyllomedusa sauvagei). It is a heptapeptide with extremely potent analgesic properties—reported to be many times stronger than morphine—while exhibiting significantly lower risk of tolerance development. Because of its unique affinity for mu-opioid receptors, Dermorphin has attracted considerable interest in scientific research related to pain management, neurobiology, and peptide pharmacology.
Key Features:
-
Contains Dermorphin (lyophilized peptide powder, for research use only).
-
High binding affinity to mu-opioid receptors.
-
Demonstrates potent analgesic activity in preclinical models.
-
Lower potential for tolerance development compared to traditional opioids.
-
Investigated for its effects on pain signaling, reward pathways, and nervous system modulation.
Scientific Background:
Dermorphin’s unique amino acid sequence (containing the rare amino acid D-alanine at position 2) gives it exceptional potency and stability compared to endogenous opioid peptides like endorphins. Preclinical studies suggest its analgesic strength may be 30–40 times greater than morphine, with reduced side effects such as respiratory depression and dependence. These properties make Dermorphin a valuable candidate for scientific exploration in the fields of pain control, addiction studies, and receptor pharmacology.
Potential Research Applications:
-
Investigation of pain modulation pathways.
-
Studies on mu-opioid receptor pharmacodynamics.
-
Research into alternative analgesics with reduced dependency risks.
-
Examination of structure–activity relationships (SARs) in opioid peptides.
Storage Guidelines:
-
Store lyophilized peptide at -20°C or below.
-
Once reconstituted, keep refrigerated at 2–8°C.
-
Avoid repeated freeze-thaw cycles to maintain peptide stability.